Healthcare: many challenges ahead

The healthcare industry is increasingly becoming resource-constrained.  A new generation of products and technological advances are making it challenging for companies to seek out the right investment opportunities for their businesses, investment opportunities that satisfy both societal and shareholder needs. At Arthur D. Little, we help clients realise the full value of their medical innovations by leveraging our team’s talent and industry expertise in a way that challenges traditional thinking but leads to solutions that are competitive and sustainable.

When assessing and setting R&D priorities, companies must build the necessary organizational structure and processes and launch appropriate cultural change in order to grow and profit from their technology investments. To enable our clients’ success, we apply our industry expertise in medical and pharmaceutical [...]

| |Bookmark Arthur D. Little

Viewpoints17 March 2017

Funding lower-priority clinical trials

Exploring a new mechanism to fund the timely execution of deprioritized trials

Introduction: Some biopharma companies have built pipelines that offer more development opportunities than their resources allow them to pursue. Promising clinical trials may be moved down the priority list and their execution delayed - [...]

Viewpoints27 January 2017

Building the Smart Hospital Agenda

A comprehensive approach for Hospitals executives to develop their Smart Hospital Strategy and Implementation program

A number of factors have been contributing to a rapid change in care delivery models world-wide. Increasing cost of care, need to improve access to care, inherent complexity in treatment options and increasing involvement of patients in [...]

Viewpoints19 January 2017

The Future of Healthcare

How to embrace the opportunity?

Unprecedented changes are ahead of us: artificial intelligence, the internet of things, big data, and social and commercial networks are radically changing the way we live and do business, and the impact of these changes will go above and [...]

Viewpoints01 March 2016

Impact of Digital Health on the Pharmaceutical Industry

Will Business Models be Reshaped by Digital Health?

Digital Health will transform the business models of the Pharmaceutical industry. Although many companies have not yet formulated a concise Digital Health strategy, industry executives expect that by 2020, Digital Health will enable [...]